World
CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Cancer drug shows promise in treating K.S.
Phase II human trials of Bristol-Myers Squibb's anticancer drug paclitaxel--already approved to treat some cases of breast, ovarian, and lung cancers under the brand name Taxol--have shown that the drug is effective in treating advanced AIDS-related Kaposi's sarcoma, AIDS Policy & Law reports. The medication appears most useful in treating K.S. in patients who have failed other chemotherapy agents. The drug was evaluated in 107 male patients with advanced K.S. who had failed at least one previous regimen of systemic chemotherapy. More than half of the patients experienced a complete or partial response to the drug. Additional data from the clinical trial is expected to be released later this year. Phase III trials are planned.
From our Sponsors
Most Popular
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Queer Youth Negatively Affected by Anti-LGBTQ+ Laws, Debates: Trevor Project Poll
January 20 2023 5:18 PM
Emanuele Crialese on His Autobiographical Coming-of-age Trans Film, L'immensitÃ
January 19 2023 8:02 PM
CPAC's Matt Schlapp & Wife Sued By GOP Staffer For Sex Harassment, Defamation
January 19 2023 5:13 PM
'Elm Street' Star Mark Patton Hospitalized With AIDS Complications, Seeks Help
January 19 2023 9:12 AM